<DOC>
	<DOCNO>NCT02597998</DOCNO>
	<brief_summary>The aim study assess mass balance recovery excreta carbon 14 label BI409306 ( [ 14C ] BI 409306 ) healthy , CYP2C19 genotyped subject provide plasma , urine faecal sample metabolite profile structural identification .</brief_summary>
	<brief_title>Metabolism Pharmacokinetics 14C-BI 409306 After Administration Oral Solution Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Inclusion criterion : 1 . Healthy male genotyped CY2C19 poor metabolizer ( PM ) extensive metabolizer ( EM ) accord investigator 's assessment , base complete medical history include physical examination , vital sign ( BP Blood Pressure , PR Pulse Rate ) , 12lead ECG ( Electrogardiogramm ) , clinical laboratory test . PM define carrier two nonfunctional allele *2 *3 CYP2C19 gene ( diplotypes *2/*2 ; *2/*3 ; *3/*3 ) . EM define carrier two functional allele CYP2C19 gene ( absence *2 , *3 , *17 ; diplotype *1/*1 ) . 2 . Age 30 65 year ( incl. ) . 3 . BMI ( Body Mass Index ) 18.5 29.9 kg/m2 ( incl. ) . 4 . Signed date write informed consent prior admission study accordance GCP local legislation . 5 . A history regular bowel movement ( average 1 bowel movement per day ; subject regular bowel movement &gt; 3 per day exclude ) . 6 . Subjects sexually active must use , partner , 2 approve method highly effective contraception time IMP administration 90 day last dose IMP . Exclusion criterion : 1 . Any finding medical examination ( include BP Blood Pressure , PR Pulse Rate ECG Electrocardiogramm ) deviate normal judge clinically relevant investigator 2 . Repeated measurement systolic blood pressure outside range 90 140 mmHg , diastolic blood pressure outside range 50 90 mmHg , pulse rate outside range 45 90 bpm 3 . Any laboratory value outside reference range investigator considers clinical relevance 4 . Any evidence concomitant disease judge clinically relevant investigator 5 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder . Any significant history ocular eye disease . 6 . Surgery gastrointestinal tract could interfere kinetics trial medication ( except appendectomy simple hernia repair ) 7 . Diseases central nervous system ( include limit kind seizure stroke ) , relevant neurological psychiatric disorder</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>